Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
High Apolipoprotein A-I Levels Associated with Giant Cell Arteritis
1
Mins
March 2024
New research finds an association between the development of GCA and higher levels of apolipoprotein A-I at baseline.
Read more
1
Mins
29th October 2021
COVID-19 Vaccination in People with Multiple Sclerosis
Consequently, for interferon-β, teriflunomide, and dimethyl fumarate, COVID-19 vaccination is “likely to be effective…”
1
Mins
2nd August 2021
Treating Ankylosing Spondylitis Using Engineered JAK Inhibitor: Upadacitinib
Researchers explored the efficacy of upadacitinib in treating AS. Upadacitinib targets the inflammatory pathway and works by inhibiting JAK, reducing the ability of JAK to cause inflammation in the joints.
1
Mins
2nd August 2021
Effective Novel Drug for Axial Psoriatic Arthritis
Phase III clinical trials analysed the efficaPhase III clinical trials analysed the efficacy of a novel antibody, guselkumab, for psoriatic arthritis with axial symptoms.
1
Mins
6th May 2021
A Prescription of Aerobic Exercise for Rheumatic Disorders
EXERCISE reduces the risk of cardiovascular disease in those with rheumatic disorders. Individuals with autoimmune rheumatic diseases (ARDs), such as rheumatoid arthritis and lupus, are more likely to develop atherosclerosis and are thereby at a higher risk of a heart attack and other cardiovascular disorders.
1
Mins
6th May 2021
A Safer Strategy for Steroid Use in Patients with Lupus
LUPUS could now be treated with a lower dose of steroids, lessening the side effects experienced by patients and improving their health long-term. The research was published by Eric Morand and the Rheumatology Group at Monash University, Melbourne, Australia, who aimed to gain insight into ways of tracking patient exposure to steroids.
1
Mins
5th February 2021
Could Colchicine Cut COVID-19 Hospital Admissions and Deaths?
COLCHICINE, an anti-inflammatory oral drug commonly used for the treatment of gout and rheumatic diseases, has reportedly been shown to significantly…
1
Mins
5th February 2021
Osteopontin and Lung Scarring in Scleroderma
OSTEOPONTIN (OPN), a protein known to function as an immune system modulator and play a role in tissue regeneration, may be responsible for driving lung…
1
Mins
30th October 2020
EULAR Releases First Core Data for Rheumatology in Pregnancy
THE EUROPEAN League Against Rheumatism (EULAR) has collated and released its first consensus-based recommendations for prospective pregnancy registries…
Loading posts...
« Previous
1
2
3
4
5
6
…
15
Next »